Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China · Delayed Price · Currency is CNY 6.22
+0.09 (1.47%)
Nov 6, 2026, 11:55 AM CST
SHE:002872 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 278.09 | 280.47 | 270.42 | 192.71 | 278.25 | 338.68 |
Trading Asset Securities | - | - | - | - | - | 82 |
Cash & Short-Term Investments | 278.09 | 280.47 | 270.42 | 192.71 | 278.25 | 420.68 |
Cash Growth | -0.14% | 3.72% | 40.32% | -30.74% | -33.86% | 26.81% |
Accounts Receivable | 129.09 | 141.52 | 158.01 | 181.16 | 195.01 | 240.01 |
Other Receivables | 139.47 | 147.09 | 159.58 | 170.94 | 186.77 | 80.85 |
Receivables | 268.56 | 288.61 | 317.59 | 352.11 | 381.78 | 320.87 |
Inventory | 93.83 | 101.31 | 106.8 | 136.22 | 130.87 | 124.58 |
Prepaid Expenses | - | 0 | 0 | - | - | - |
Other Current Assets | 12.34 | 9.26 | 7.63 | 10 | 25.18 | 54.08 |
Total Current Assets | 652.82 | 679.65 | 702.44 | 691.04 | 816.08 | 920.21 |
Property, Plant & Equipment | 1,290 | 1,334 | 1,464 | 1,581 | 1,613 | 1,638 |
Long-Term Investments | 54.67 | 52.93 | 47.02 | 52.7 | 52.46 | 50 |
Other Intangible Assets | 250.29 | 258.43 | 285.9 | 311.77 | 319.5 | 327.14 |
Long-Term Deferred Tax Assets | 85.74 | 84.2 | 77.58 | 68.07 | 64.97 | 69.15 |
Long-Term Deferred Charges | 15.4 | 18.37 | 23.4 | 16.33 | 11.74 | 14.51 |
Other Long-Term Assets | 213.68 | 216.22 | 135.44 | 89.98 | 92.64 | 101.44 |
Total Assets | 2,563 | 2,644 | 2,736 | 2,811 | 2,971 | 3,120 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 39.88 | 48.07 | 46.47 | 77.34 | 55.31 | 126.45 |
Accrued Expenses | 7.52 | 19.32 | 14.34 | 10.28 | 25.27 | 14.52 |
Short-Term Debt | 246.02 | 86.29 | 80.28 | 117.34 | 89.59 | 132.42 |
Current Portion of Long-Term Debt | 95.2 | 113.86 | 49.5 | 82.98 | 143.45 | 49.59 |
Current Portion of Leases | - | 0.87 | 0.83 | 1.62 | 2.18 | 2.71 |
Current Income Taxes Payable | 10.09 | 0.47 | 0.53 | 0.46 | 3.19 | 0.5 |
Current Unearned Revenue | 16.71 | 21.43 | 23.36 | 38.42 | 46.73 | 25.65 |
Other Current Liabilities | 91.77 | 125.33 | 144.01 | 126.12 | 189.68 | 120.72 |
Total Current Liabilities | 507.2 | 415.66 | 359.31 | 454.55 | 555.39 | 472.55 |
Long-Term Debt | 9.9 | 157.08 | 234.54 | 118.8 | 89.65 | 219.42 |
Long-Term Leases | 1.21 | 1.29 | 2.45 | 4.84 | 4.3 | 9.65 |
Long-Term Unearned Revenue | 105.51 | 106.58 | 115.42 | 127.79 | 126.34 | 131.46 |
Long-Term Deferred Tax Liabilities | 4.48 | 4.76 | 4.07 | 4.47 | 2.84 | 2.81 |
Other Long-Term Liabilities | 20 | - | 6 | 4.8 | 4.54 | 4.9 |
Total Liabilities | 648.3 | 685.37 | 721.8 | 715.25 | 783.06 | 840.79 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 318 | 318 | 318 | 318 | 318 | 318 |
Additional Paid-In Capital | 1,401 | 1,401 | 1,401 | 1,401 | 1,401 | 1,401 |
Retained Earnings | 181.53 | 225.3 | 280.72 | 368.12 | 461.2 | 551.76 |
Comprehensive Income & Other | 7.29 | 6.95 | 6.18 | 4.58 | 2.8 | 2.89 |
Total Common Equity | 1,908 | 1,951 | 2,006 | 2,091 | 2,183 | 2,273 |
Minority Interest | 6.72 | 7.62 | 8.64 | 4.18 | 4.82 | 5.81 |
Shareholders' Equity | 1,914 | 1,959 | 2,014 | 2,096 | 2,188 | 2,279 |
Total Liabilities & Equity | 2,563 | 2,644 | 2,736 | 2,811 | 2,971 | 3,120 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 352.33 | 359.4 | 367.61 | 325.58 | 329.17 | 413.78 |
Net Cash (Debt) | -74.24 | -78.93 | -97.19 | -132.86 | -50.92 | 6.89 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.23 | -0.25 | -0.31 | -0.42 | -0.16 | 0.02 |
Filing Date Shares Outstanding | 318.06 | 318 | 318 | 318 | 318 | 318 |
Total Common Shares Outstanding | 318.06 | 318 | 318 | 318 | 318 | 318 |
Working Capital | 145.62 | 263.99 | 343.12 | 236.49 | 260.69 | 447.65 |
Book Value Per Share | 6.00 | 6.14 | 6.31 | 6.58 | 6.86 | 7.15 |
Tangible Book Value | 1,657 | 1,693 | 1,720 | 1,780 | 1,863 | 1,946 |
Tangible Book Value Per Share | 5.21 | 5.32 | 5.41 | 5.60 | 5.86 | 6.12 |
Buildings | - | 1,628 | 1,676 | 1,663 | 1,420 | 1,402 |
Machinery | - | 554.45 | 535.34 | 533.41 | 516.98 | 520.48 |
Construction In Progress | - | 17.14 | 33.8 | 81.96 | 291.84 | 252.61 |